Thermostable Vaccine Market Growth, Innovations and Market Size Forecast 2035
According to our projections, the thermostable vaccine sector is expected to grow from USD 9.27 billion in 2025 to USD 19.05 billion by 2035, reflecting a CAGR of 7.47%. The thermostable vaccine market is growing fast, driven by the need for heat-resistant vaccines that don’t require cold storage. These innovative vaccines improve access in remote areas, making immunization safer and more reliable worldwide.
Last Updated : 03 August 2026Category: BiotechnologyInsight Code: 5117Format: PDF / PPT / Excel
Regulatory Framework for Leading Countries/Regions
Supply Demand Analysis
Production & Consumption Statistics
Export Import Statistics
Price Trend Analysis
Global Thermostable Vaccine Market Assessment
Overview
Global Thermostable Vaccine Market Size Value (US$) and Volume (Million Tons), by Vaccine Type (2021 – 2033)
Viral Vaccine
Bacterial Vaccine
Parasitic Vaccine
Other Vaccines
Global Thermostable Vaccine Market Size Value (US$) and Volume (Million Tons), by Application (2021 – 2033)
Human Health
Animal Health
Global Thermostable Vaccine Market Size Value (US$) and Volume (Million Tons), by Development Stage (2021 – 2033)
Preclinical Research
Clinical Trials
Approved Drugs
Global Thermostable Vaccine Market Size Value (US$) and Volume (Million Tons), by Geography (2021 – 2033)
North America
Europe
Asia-Pacific
Latin America
Middle East and Africa
North America Thermostable Vaccine Market Assessment
Overview
North America Thermostable Vaccine Market Size Value (US$) and Volume (Million Tons), by Vaccine Type (2021 – 2033)
Viral Vaccine
Bacterial Vaccine
Parasitic Vaccine
Other Vaccines
North America Thermostable Vaccine Market Size Value (US$) and Volume (Million Tons), by Application (2021 – 2033)
Human Health
Animal Health
North America Thermostable Vaccine Market Size Value (US$) and Volume (Million Tons), by Development Stage (2021 – 2033)
Preclinical Research
Clinical Trials
Approved Drugs
Europe Thermostable Vaccine Market Assessment
Overview
Europe Thermostable Vaccine Market Size Value (US$) and Volume (Million Tons), by Vaccine Type (2021 – 2033)
Viral Vaccine
Bacterial Vaccine
Parasitic Vaccine
Other Vaccines
Europe Thermostable Vaccine Market Size Value (US$) and Volume (Million Tons), by Application (2021 – 2033)
Human Health
Animal Health
Europe Thermostable Vaccine Market Size Value (US$) and Volume (Million Tons), by Development Stage (2021 – 2033)
Preclinical Research
Clinical Trials
Approved Drugs
Asia Pacific Thermostable Vaccine Market Assessment
Overview
Asia Pacific Thermostable Vaccine Market Size Value (US$) and Volume (Million Tons), by Vaccine Type (2021 – 2033)
Viral Vaccine
Bacterial Vaccine
Parasitic Vaccine
Other Vaccines
Asia Pacific Thermostable Vaccine Market Size Value (US$) and Volume (Million Tons), by Application (2021 – 2033)
Human Health
Animal Health
Asia Pacific Thermostable Vaccine Market Size Value (US$) and Volume (Million Tons), by Development Stage (2021 – 2033)
Preclinical Research
Clinical Trials
Approved Drugs
Latin America Thermostable Vaccine Market Assessment
Overview
Latin America Thermostable Vaccine Market Size Value (US$) and Volume (Million Tons), by Vaccine Type (2021 – 2033)
Viral Vaccine
Bacterial Vaccine
Parasitic Vaccine
Other Vaccines
Latin America Thermostable Vaccine Market Size Value (US$) and Volume (Million Tons), by Application (2021 – 2033)
Human Health
Animal Health
Latin America Thermostable Vaccine Market Size Value (US$) and Volume (Million Tons), by Development Stage (2021 – 2033)
Preclinical Research
Clinical Trials
Approved Drugs
Middle East and Africa Thermostable Vaccine Market Assessment
Overview
Middle East and Africa Thermostable Vaccine Market Size Value (US$) and Volume (Million Tons), by Vaccine Type (2021 – 2033)
Viral Vaccine
Bacterial Vaccine
Parasitic Vaccine
Other Vaccines
Middle East and Africa Thermostable Vaccine Market Size Value (US$) and Volume (Million Tons), by Application (2021 – 2033)
Human Health
Animal Health
Middle East and Africa Thermostable Vaccine Market Size Value (US$) and Volume (Million Tons), by Development Stage (2021 – 2033)
Preclinical Research
Clinical Trials
Approved Drugs
Company Profiles
Serum Institute of India
Company Overview
Geographic Footprints
Financial Performance
Product Portfolio
SWOT Analysis
R&D Efforts
Recent Developments & Strategic Collaborations
Product Launch/M&A/Technical Collaboration
Sanofi
GSK
Hilleman Laboratories
Soligenix
Conclusion & Recommendations
FAQ's
Answer : The thermostable vaccine market is valued at USD 9.96 billion in 2026 and is projected to nearly double to USD 19.05 billion by 2035, growing at a steady 7.47% CAGR.
Answer : The biggest trend is moving beyond cold-chain dependency. Advances in freeze-dried formulations, heat-stable mRNA vaccines, and room-temperature storage are reshaping vaccine logistics.
Answer : Major players like Serum Institute of India, Sanofi, GSK, Hilleman Laboratories, and Soligenix are at the forefront.
Payal Rabde is a Healthcare Market Research Analyst at Towards Healthcare Research & Consulting with 4+ years of experience in pharmaceuticals, biotechnology, medical devices, and life sciences.
Aditi Shivarkar is a seasoned professional with over 14 years of experience in healthcare
market research. As a content reviewer, Aditi ensures the quality and accuracy of all market
insights and data presented by the research team.
We use cookies that are necessary to make our site work. We may also use additional cookies to analyze,
improve, and personalize our content and your digital experience.
You can manage your cookie preferences using the
Privacy Policy
For more information, see our
Terms and Conditions
.
Cookie Preference Center
We use cookies which are necessary to make our site work.
We may also use additional cookies to analyze, improve and personalize
our content and your digital experience.
For more information, please read our
Cookie Policy
.
You may choose not to allow some types of cookies.
Blocking some cookies may impact your experience of the site.